Table 2.
Protein name | Short name | Uniprot ID | Antibody | bvFTD vs NC | bvFTD vs PMC | FTD vs unaffected | Direction of changec |
---|---|---|---|---|---|---|---|
Neurosecretory protein VGF | VGF | O15240 | HPA055177 | 0.0002 | 0.0003 | 0.0001b | ↓ |
Tenascin-R | TN-R | Q92752 | HPA027150 | 0.0008 | 0.002 | 0.0007b | ↑ |
Neuronal pentraxin receptor | NPTXR | O95502 | HPA001079 | 0.003 | 0.008 | 0.0005b | ↓ |
Transmembrane protein 132D | TMEM132D | Q14C87 | HPA010739 | 0.003 | 0.008 | 0.0007 | ↓ |
Prodynorphin | PDYN | P01213 | HPA053342 | 0.003 | 0.006 | 0.0007b | ↓ |
Neurocan core protein | NCAN | O14594 | HPA058000 | 0.003 | 0.006 | 0.0007b | ↓ |
Calsyntenin-1 | CLSTN1 | O94985 | HPA012749a | 0.003 | 0.01 | 0.0009b | ↓ |
Cadherin-8 | CDH8 | P55286 | HPA014908 | 0.003 | 0.01 | 0.001 | ↓ |
Neural cell adhesion molecule L1-like protein | CHL1 | O00533 | HPA003345 | 0.003 | 0.02 | 0.003b | ↓ |
Rabphilin-3A | RPH3A | Q9Y2J0 | HPA002475 | 0.004 | 0.01 | 0.001 | ↓ |
Peptidyl-glycine alpha-amidating monooxygenase | PAM | P19021 | HPA042260a | 0.004 | 0.02 | 0.005b | ↓ |
Neuronal pentraxin-1 | NP1 | Q15818 | HPA077062 | 0.006 | 0.02 | 0.0007 | ↓ |
von Willebrand factor C domain-containing protein 2-like | VWC2L | B2RUY7 | HPA059414 | 0.006 | 0.01 | 0.003 | ↑ |
Tripeptidyl-peptidase 1 | TPP-1 | O14773 | HPA037709 | 0.008 | 0.02 | 0.002 | ↑ |
Amyloid-like protein 1 | APLP-1 | P51693 | HPA028971 | 0.008 | 0.05 | 0.009 | ↓ |
Apolipoprotein A-I | ApoA-I | P02647 | HPA046715a | 0.01 | 0.04 | 0.001 | ↑ |
Neurofilament medium polypeptide | NF-M | P07197 | HPA022845 | 0.02 | 0.02 | 0.0007b | ↑ |
Neurofilament medium polypeptide | NF-M | P07197 | HPA023138 | 0.02 | 0.02 | 0.0008b | ↑ |
Leucine-rich alpha-2-glycoprotein | LRG | P02750 | HPA001888a | 0.02 | 0.03 | 0.002 | ↑ |
Alpha-1-antichymotrypsin | ACT | P01011 | HPA000893a | 0.02 | 0.03 | 0.003 | ↑ |
UPF0606 protein KIAA1549L | KIAA1549L | Q6ZVL6 | HPA051594 | 0.02 | 0.02 | 0.005 | ↓ |
Inter-alpha-trypsin inhibitor heavy chain H1 | ITI-HC1 | P19827 | HPA042049a | 0.02 | 0.03 | 0.005 | ↑ |
Oligodendrocyte-myelin glycoprotein | OMG | P23515 | HPA008206a | 0.02 | 0.02 | 0.006b | ↓ |
Neuronal cell adhesion molecule | Nr-CAM | Q92823 | HPA061433 | 0.02 | 0.02 | 0.006 | ↓ |
TAR DNA-binding protein 43 | TDP-43 | Q13148 | HPA070770 | 0.02 | 0.01 | 0.006 | ↑ |
Brevican core protein | BEHAB | Q96GW7 | HPA007865 | 0.06 | 0.02 | 0.008 | ↓ |
Phosphoinositide-3-kinase-interacting protein 1 | PIK3IP1 | Q96FE7 | HPA007353a | 0.08 | 0.04 | 0.009 | ↓ |
P-values (FDR adjusted) based on Mann Whitney U tests for each statistically significant sub group comparison. Group comparisons with PPA (PPA vs NC, PPA vs PMC and PPA vs bvFTD) and between unaffected (NC vs PMC) were not statistically significant
a The generalized linear model showed a significant (p < 0.05) age effect
b The result could be replicated in the second cohort
c Direction of change in FTD compared to unaffected individuals